Radiation-free fetal heart rate monitor market seen growing to $2.36 billion by 2030

The radiation-free fetal heart rate monitor market is forecast to expand from $1.48 billion in 2025 to $2.36 billion by 2030, driven by prenatal care awareness, high-risk pregnancies and remote monitoring. North America led in 2025, while Asia-Pacific is projected to grow fastest.

Why it matters: - Radiation-free fetal heart rate monitors support safer prenatal monitoring because they track fetal heartbeat without ionizing radiation. - The market’s growth points to stronger demand for remote, at-home and continuous maternal care tools. - Rising adoption could expand access to earlier detection of fetal abnormalities and faster medical intervention.

What happened: - The Business Research Company published a 2026 report on the radiation-free fetal heart rate monitor market. - The market is estimated at $1.48 billion in 2025 and is projected to reach $1.62 billion in 2026. - The report forecasts the market will grow to $2.36 billion by 2030. - The market is expected to post a 9.7% CAGR in the historical period and a 9.9% CAGR through 2030.

The details: - Radiation-free fetal heart rate monitors use non-invasive technologies such as Doppler ultrasound. - The devices provide continuous real-time tracking of fetal heart activity. - The report links recent growth to prenatal health awareness, more high-risk pregnancies, better non-invasive diagnostics, wider use of portable healthcare gadgets and stronger maternal health infrastructure. - Forecast-period growth is tied to demand for remote pregnancy monitoring, AI-powered fetal analysis, wearable health technologies, telehealth services and investment in prenatal diagnostic instruments. - The report highlights growing interest in continuous real-time monitoring, portable home-based devices, wireless wearable fetal monitors and early detection of fetal abnormalities. - A free sample is available here. - The full report is available here. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America and the Middle East and Africa. - The report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The market’s momentum reflects a broader shift in maternal care toward monitoring outside the hospital. - High-risk pregnancies are increasing pressure for devices that can track fetal health safely and continuously. - Telehealth and remote patient monitoring are becoming more central to prenatal care workflows, which should favor connected devices. - North America led the market in 2025, but faster growth in Asia-Pacific suggests demand is broadening geographically. - The report cites UK antenatal data showing 63.5% of women attended their first appointment within 10 weeks of pregnancy in December 2024, underscoring earlier prenatal engagement. - The report also cites US fetal-death data for 2023 totaling 20,005 deaths at 20 weeks or later gestation, reinforcing the need for vigilant monitoring in high-risk pregnancies.

What's next: - The market is expected to keep expanding as remote monitoring, telehealth and wearable fetal devices become more common. - Asia-Pacific is projected to be the fastest-growing region during the forecast period. - Continued investment in AI-enabled analysis and prenatal diagnostics could shape the next phase of product development. - Wider use of home-based monitoring may push more care from clinics into the home.